Eli Lilly LLY Net debt / EBITDA

Net debt / EBITDA at other companies

PfizerPFE

3.8×—

AmgenAMGN

3.7×-0.7×

Cardinal HealthCAH

1.5×+0.1×

MannkindMNKD

-1.4×+5.5×

McKessonMCK

-0.3×-0.9×

ExelixisEXEL

-0.1×-0.1×

FAQ

What is Eli Lilly's net debt / EBITDA?

Eli Lilly (LLY) reported net debt / EBITDA of 1.1× in Q1 2026.

How has Eli Lilly's net debt / EBITDA changed year-over-year?

Eli Lilly's net debt / EBITDA decreased by 50.0% year-over-year, from 2.3× to 1.1×.

What is the long-term trend for Eli Lilly's net debt / EBITDA?

Over 5 years (2020 to 2025), Eli Lilly's net debt / EBITDA has grown at a -4.3% compound annual growth rate (CAGR), from 1.6× to 1.3×.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.